Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

2(29%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

57%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

N/ANon-phased studies

4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(3)

Other(2)

Detailed Status

Completed3

Recruiting2

unknown2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed343%

recruiting229%

unknown229%

Recent Activity

2 active trials

Showing 5 of 7

completednot_applicable

Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants

NCT05161169

recruitingnot_applicable

Clinical Trials (7)

Showing 7 of 7 trials

NCT05161169Not Applicable

Implementation of Whole Genome Sequencing as Screening in a Diverse Cohort of Healthy Infants

Completed

NCT06762795Not Applicable

The HIEnome Study: Genome Sequencing for Perinatal HIE

Recruiting

NCT02155621Not Applicable

Personalized Oncogenomics (POG) Program of British Columbia

Recruiting

NCT03380819Not Applicable

The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care

Completed

NCT05764850

Mechanisms of Type 1 Diabetes Endophenotypes

Unknown

NCT03956069

Study of the Diagnostic Value of "Rapid" High Throughput Genome Sequencing Analysis in Diagnostic Emergency Situations

Completed

NCT03053999

Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)

Unknown

All 7 trials loaded

Drug Details

Intervention Type: GENETIC
Total Trials: 7